“Myeloma Patients with Negative T-spot Results after COVID-19 Vaccination Likely Have Low Antibody Levels, Predictive Biomarkers for T Cell Responses”

https://pubmed.ncbi.nlm.nih.gov/38116695

Myeloma patients with negative T-spot results after COVID-19 vaccination are more likely to have low antibody levels, and certain biomarkers can predict T cell responses in this population.